Tech Company Financing Transactions

Biolex Funding Round

Clarus, Intersouth Partners and Investor Growth Capital joined a $60 million Series D funding round for Biolex. The round closed on 10/6/2008.

Transaction Overview

Company Name
Biolex
Announced On
10/6/2008
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series D
Investors

Clarus (Lead Investor) (Jeffrey Leiden)

Intersouth Partners

Investor Growth Capital (Liza Nelson)

Johnson & Johnson Development Corporation

JPMorgan Partners

Mitsui & Co. Venture Partners

OrbiMed (Klaus Veitinger)

Polaris Partners (Kevin Bitterman)

Quaker Partners (Sherrill Neff)

Proceeds Purpose
This financing is designed to prepare Locteron for Phase 3 development, including the completion of ongoing and planned Phase 2 testing.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
158 Credle St.
Pittsboro, NC 27312
USA
Phone
(919) 542-9901
Website
www.biolex.com
Email Address
[email protected]
Overview
Biolex, Inc. is a biopharmaceutical company devoted to discovering, developing and commercializing its proprietary advanced protein expression technology for the development of human therapeutics.
Profile
Biolex LinkedIn Company Profile
Social Media
Biolex Company Twitter Account
Company News
Biolex News
Facebook
Biolex on Facebook
YouTube
Biolex on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jan Turek
  Jan Turek LinkedIn Profile  Jan Turek Twitter Account  Jan Turek News  Jan Turek on Facebook
Chief Financial Officer
Dale Sander
  Dale Sander LinkedIn Profile  Dale Sander Twitter Account  Dale Sander News  Dale Sander on Facebook
Chief Medical Officer
Walker Long
  Walker Long LinkedIn Profile  Walker Long Twitter Account  Walker Long News  Walker Long on Facebook
VP - Bus. Development
Bipin Dalmia
  Bipin Dalmia LinkedIn Profile  Bipin Dalmia Twitter Account  Bipin Dalmia News  Bipin Dalmia on Facebook
VP - R & D
Lynn Dickey
  Lynn Dickey LinkedIn Profile  Lynn Dickey Twitter Account  Lynn Dickey News  Lynn Dickey on Facebook
VP - R & D
David Spencer
  David Spencer LinkedIn Profile  David Spencer Twitter Account  David Spencer News  David Spencer on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/6/2008: Alien Technology venture capital transaction
Next: 10/6/2008: Crocus Technology venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.